GeneBioTech (Korea) Market Value
| 086060 Stock | KRW 3,415 65.00 1.94% |
| Symbol | GeneBioTech |
GeneBioTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneBioTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneBioTech.
| 11/18/2024 |
| 12/18/2024 |
If you would invest 0.00 in GeneBioTech on November 18, 2024 and sell it all today you would earn a total of 0.00 from holding GeneBioTech Co or generate 0.0% return on investment in GeneBioTech over 30 days. GeneBioTech is related to or competes with Haesung Industrial, CU Medical, Myoung Shin, Hansol Homedeco, Youngsin Metal, Kyeryong Construction, and LEENO Industrial. Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resource... More
GeneBioTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneBioTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneBioTech Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.75 | |||
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 8.04 | |||
| Value At Risk | (2.39) | |||
| Potential Upside | 2.68 |
GeneBioTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneBioTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneBioTech's standard deviation. In reality, there are many statistical measures that can use GeneBioTech historical prices to predict the future GeneBioTech's volatility.| Risk Adjusted Performance | 0.0058 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | (0.13) |
GeneBioTech Backtested Returns
GeneBioTech holds Efficiency (Sharpe) Ratio of -0.008, which attests that the entity had a -0.008% return per unit of risk over the last 3 months. GeneBioTech exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GeneBioTech's Downside Deviation of 1.75, market risk adjusted performance of (0.12), and Risk Adjusted Performance of 0.0058 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.074, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GeneBioTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding GeneBioTech is expected to be smaller as well. At this point, GeneBioTech has a negative expected return of -0.0139%. Please make sure to check out GeneBioTech's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if GeneBioTech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.58 |
Good reverse predictability
GeneBioTech Co has good reverse predictability. Overlapping area represents the amount of predictability between GeneBioTech time series from 18th of November 2024 to 3rd of December 2024 and 3rd of December 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneBioTech price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current GeneBioTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.58 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 8609.5 |
GeneBioTech lagged returns against current returns
Autocorrelation, which is GeneBioTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GeneBioTech's stock expected returns. We can calculate the autocorrelation of GeneBioTech returns to help us make a trade decision. For example, suppose you find that GeneBioTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GeneBioTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GeneBioTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GeneBioTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GeneBioTech stock over time.
Current vs Lagged Prices |
| Timeline |
GeneBioTech Lagged Returns
When evaluating GeneBioTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GeneBioTech stock have on its future price. GeneBioTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GeneBioTech autocorrelation shows the relationship between GeneBioTech stock current value and its past values and can show if there is a momentum factor associated with investing in GeneBioTech Co.
Regressed Prices |
| Timeline |
Pair Trading with GeneBioTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneBioTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneBioTech will appreciate offsetting losses from the drop in the long position's value.Moving together with GeneBioTech Stock
The ability to find closely correlated positions to GeneBioTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneBioTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneBioTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneBioTech Co to buy it.
The correlation of GeneBioTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneBioTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneBioTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneBioTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in GeneBioTech Stock
GeneBioTech financial ratios help investors to determine whether GeneBioTech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GeneBioTech with respect to the benefits of owning GeneBioTech security.